SH T00186 in the Treatment of Primary Dysmenorrhea

PHASE3CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Primary Dysmenorrhea
Interventions
DRUG

Drug: YAZ flex (SH T00186D)

Extended flexible regimen of YAZ (SH T00186D); triggered by bleeding events(Tablet p.o. (oral))

DRUG

YAZ (SH T00186D)

YAZ (SH T 00186D) administered in the conventional regimen (24 days active + 4 days placebo) (Tablet p.o. (oral))

Trial Locations (27)

10247

Berlin

10409

Berlin

12587

Berlin

13086

Berlin

30159

Hanover

30459

Hanover

36037

Fulda

38889

Blankenburg

39104

Magdeburg

39126

Magdeburg

39130

Magdeburg

39288

Burg

60439

Frankfurt am Main

63165

Mühlheim am Main

69120

Heidelberg

90491

Nuremberg

04207

Leipzig

04277

Leipzig

04299

Leipzig

04808

Wurzen

06406

Bernburg

06917

Jessen

07545

Gera

07768

Kahla

S40 4TF

Chesterfield

NE4 5BE

Newcastle upon Tyne

W12 0HS

London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00569244 - SH T00186 in the Treatment of Primary Dysmenorrhea | Biotech Hunter | Biotech Hunter